Research progress on reactive oxygen species production mechanisms in tumor sonodynamic therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Photodynamic Therapy Research

Background:

• Sonodynamic therapy (SDT) is an emerging non-invasive cancer treatment.
• SDT's mechanism, particularly reactive oxygen species (ROS) production, requires further elucidation.
• Improving treatment safety and efficacy is a primary goal in oncology.

Purpose of the Study:

• To review the mechanisms of ROS production in SDT.
• To explore methods for enhancing ROS generation in SDT.
• To discuss current clinical applications and limitations of SDT.

Main Methods:

• Literature review of sonodynamic therapy mechanisms.
• Analysis of reactive oxygen species production pathways.
• Evaluation of sonosensitizer development for enhanced SDT.

Main Results:

• Reactive oxygen species are a key mediator in sonodynamic therapy.
• Various strategies exist to enhance sonodynamic ROS production.
• Clinical translation of SDT is limited by current challenges.

Conclusions:

• Further research should focus on developing advanced sonosensitizers.
• Sonosensitizers need to efficiently produce ROS and ensure biological safety.
• Optimizing sonosensitizers will facilitate the clinical adoption of SDT.